These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 8666779

  • 1. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes.
    Martinez C, Delgado M, Gomariz RP, Ganea D.
    J Immunol; 1996 Jun 01; 156(11):4128-36. PubMed ID: 8666779
    [Abstract] [Full Text] [Related]

  • 2. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
    Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D.
    J Immunol; 1999 Feb 01; 162(3):1707-16. PubMed ID: 9973433
    [Abstract] [Full Text] [Related]

  • 3. Vasoactive intestinal peptide inhibits IL-4 production in murine T cells by a post-transcriptional mechanism.
    Wang HY, Xin Z, Tang H, Ganea D.
    J Immunol; 1996 May 01; 156(9):3243-53. PubMed ID: 8617946
    [Abstract] [Full Text] [Related]

  • 4. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.
    Delgado M, Jonakait GM, Ganea D.
    Glia; 2002 Aug 01; 39(2):148-61. PubMed ID: 12112366
    [Abstract] [Full Text] [Related]

  • 5. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
    Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D.
    J Immunol; 1999 Apr 15; 162(8):4685-96. PubMed ID: 10202009
    [Abstract] [Full Text] [Related]

  • 6. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies.
    Delgado M, Pozo D, Martinez C, Leceta J, Calvo JR, Ganea D, Gomariz RP.
    J Immunol; 1999 Feb 15; 162(4):2358-67. PubMed ID: 9973516
    [Abstract] [Full Text] [Related]

  • 7. Down-regulation of cytokine expression in murine lymphocytes by PACAP and VIP.
    Tang H, Sun L, Xin Z, Ganea D.
    Ann N Y Acad Sci; 1996 Dec 26; 805():768-78. PubMed ID: 8993475
    [Abstract] [Full Text] [Related]

  • 8. VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells.
    Delgado M, Reduta A, Sharma V, Ganea D.
    J Leukoc Biol; 2004 Jun 26; 75(6):1122-30. PubMed ID: 15020654
    [Abstract] [Full Text] [Related]

  • 9. VIP and PACAP differentially regulate the costimulatory activity of resting and activated macrophages through the modulation of B7.1 and B7.2 expression.
    Delgado M, Sun W, Leceta J, Ganea D.
    J Immunol; 1999 Oct 15; 163(8):4213-23. PubMed ID: 10510358
    [Abstract] [Full Text] [Related]

  • 10. Neuropeptides as modulators of macrophage functions. Regulation of cytokine production and antigen presentation by VIP and PACAP.
    Ganea D, Delgado M.
    Arch Immunol Ther Exp (Warsz); 2001 Oct 15; 49(2):101-10. PubMed ID: 11348014
    [Abstract] [Full Text] [Related]

  • 11. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
    Nagakawa O, Junicho A, Akashi T, Koizumi K, Matsuda T, Fuse H, Saiki I.
    Oncol Rep; 2005 Jun 15; 13(6):1217-21. PubMed ID: 15870945
    [Abstract] [Full Text] [Related]

  • 12. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide stimulate the induction of Th2 responses by up-regulating B7.2 expression.
    Delgado M, Leceta J, Gomariz RP, Ganea D.
    J Immunol; 1999 Oct 01; 163(7):3629-35. PubMed ID: 10490956
    [Abstract] [Full Text] [Related]

  • 13. VIP1 and VIP2 receptors but not PVR1 mediate the effect of VIP/PACAP on cytokine production in T lymphocytes.
    Jiang X, Wang HY, Yu J, Ganea D.
    Ann N Y Acad Sci; 1998 Dec 11; 865():397-407. PubMed ID: 9928038
    [Abstract] [Full Text] [Related]

  • 14. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells.
    Nagata A, Tanaka T, Minezawa A, Poyurovsky M, Mayama T, Suzuki S, Hashimoto N, Yoshida T, Suyama K, Miyata A, Hosokawa H, Nakayama T, Tatsuno I.
    J Cell Physiol; 2009 Oct 11; 221(1):75-83. PubMed ID: 19496170
    [Abstract] [Full Text] [Related]

  • 15. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6.
    Delgado M, Martinez C, Pozo D, Calvo JR, Leceta J, Ganea D, Gomariz RP.
    J Immunol; 1999 Jan 15; 162(2):1200-5. PubMed ID: 9916753
    [Abstract] [Full Text] [Related]

  • 16. Lymphocyte regulation of neuropeptide gene expression after neuronal injury.
    Armstrong BD, Hu Z, Abad C, Yamamoto M, Rodriguez WI, Cheng J, Tam J, Gomariz RP, Patterson PH, Waschek JA.
    J Neurosci Res; 2003 Oct 15; 74(2):240-7. PubMed ID: 14515353
    [Abstract] [Full Text] [Related]

  • 17. The neuropeptides vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) modulate several biochemical pathways in human leukemic myeloid cells.
    Hayez N, Harfi I, Lema-Kisoka R, Svoboda M, Corazza F, Sariban E.
    J Neuroimmunol; 2004 Apr 15; 149(1-2):167-81. PubMed ID: 15020077
    [Abstract] [Full Text] [Related]

  • 18. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: players in innate and adaptive immunity.
    Ganea D, Rodriguez R, Delgado M.
    Cell Mol Biol (Noisy-le-grand); 2003 Mar 15; 49(2):127-42. PubMed ID: 12887096
    [Abstract] [Full Text] [Related]

  • 19. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit antigen-induced apoptosis of mature T lymphocytes by inhibiting Fas ligand expression.
    Delgado M, Ganea D.
    J Immunol; 2000 Feb 01; 164(3):1200-10. PubMed ID: 10640731
    [Abstract] [Full Text] [Related]

  • 20. Peptidergic activation of transcription and secretion in chromaffin cells. Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP).
    Taupenot L, Mahata SK, Wu H, O'Connor DT.
    J Clin Invest; 1998 Feb 15; 101(4):863-76. PubMed ID: 9466982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.